Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma

Published:2024-05 Issue: Volume: Page:
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wu Huantong,Zhang Guangji,Liu Zhongfeng,Liu Weihua,Wang Xuan,Zhao Yu

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference47 articles.

1. Neuroblastoma: developmental biology, cancer genomics and immunotherapy;Cheung;Nat Rev Cancer,2013

2. International incidence of childhood cancer, 2001-10: a population-based registry study;Steliarova-Foucher;Lancet Oncol,2017

3. Anti-GD2 immunotherapy for neuroblastoma;Sait;Expert Rev Anticancer Ther,2017

4. Anti-GD2 based immunotherapy prevents late events in high-risk neuroblastoma patients over 18 months at diagnosis;Tas;Cancers (Basel),2021

5. Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the Children's Oncology Group;Mody;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP